PCV51 PROJECTED LDL-C REDUCTION AND GOAL ATTAINMENT BY SWITCHING PATIENTS TO DUAL INHIBITION THERAPY (EZETIMIBE/SIMVASTATIN 10/20MG) IN SPAIN

Autor:	MT Caloto, Donald Yin, Glenn Davies, Evo Alemao, John R. Cook, G Nocea
Rok vydání:	2005
Předmět:	Dual inhibition Reduction (complexity) medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Physical therapy Medicine Ezetimibe/simvastatin Pharmacology business medicine.drug Goal attainment
Zdroj:	Value in Health. 8:A104
ISSN:	1098-3015
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6e0473d043d58e9f5bb86e15113f253 https://doi.org/10.1016/s1098-3015(10)67462-1 Zobrazit plný text záznamu Full Text from ScienceDirect Plný text